SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
New Report Says It's Time for Big Pharma to 'Play or Pay' to Tackle Superbugs
'If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm.'
May 19, 2016
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
- Reducing the unnecessary use of antimicrobial drugs in healthcare settings;
- Monitoring and reducing superfluous use of the drugs in farming;
- Quicker progress to be made on banning or restricting antibiotics that are vital for human health from being used in animals;
- Better use of diagnostic tools to help reduce unnecessary use of the drugs;
- A global public awareness campaign about the problem of drug resistance;
- Increasing the supply of new antibiotic drugs.
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
- Reducing the unnecessary use of antimicrobial drugs in healthcare settings;
- Monitoring and reducing superfluous use of the drugs in farming;
- Quicker progress to be made on banning or restricting antibiotics that are vital for human health from being used in animals;
- Better use of diagnostic tools to help reduce unnecessary use of the drugs;
- A global public awareness campaign about the problem of drug resistance;
- Increasing the supply of new antibiotic drugs.
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.
A new plan for tackling the growing threat of antibiotic-resistant microbes, or so-called superbugs, addresses the unnecessary use of antibiotics and includes a call on Big Pharma to "play or pay" to help bring successful treatments to the market.
The report, commissioned by British Prime Minister David Cameron, was led by economist Jim O'Neill, who said that antibiotics were sometimes being handed out "like sweets."
"If we don't do something, we're heading towards a world where there will be no antibiotics available to treat people who need them," O'Neill told reporters at a London briefing.
Among the recommendations his report lays out, as noted by Press Association, are:
- Reducing the unnecessary use of antimicrobial drugs in healthcare settings;
- Monitoring and reducing superfluous use of the drugs in farming;
- Quicker progress to be made on banning or restricting antibiotics that are vital for human health from being used in animals;
- Better use of diagnostic tools to help reduce unnecessary use of the drugs;
- A global public awareness campaign about the problem of drug resistance;
- Increasing the supply of new antibiotic drugs.
Explaining the "pay or play" proposal, Reuters reports that O'Neill's plan is for pharmaceutical companies to
be subject to a surcharge if they decide not to invest in research and development (R&D) to bring successful new antibiotic medicines to market.
For [those] who do decide to "play", he said, a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.
But that approach wouldn't be a panacea, said Dr. Grania Brigden, from the medical charity Medecins Sans Frontieres.
"The O'Neill report proposes considerable new funding to overcome the failures of pharmaceutical research and development, but the proposals do not necessarily ensure access to either existing tools or emerging new products," the BBC reports her as saying.
Addressing antibiotics being doled out in cases when it is not necessary, O'Neill called for "rapid diagnostics" to help determine if a patient is suffering from an infection that is, in fact, bacterial, as opposed to viral.
"II find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient's symptoms, just like they used to when antibiotics first entered common use in the 1950s," O'Neill said in the report.
From the Guardian:
O'Neill said that stopping the over-use of antibiotics - also fed in vast quantities to animals for growth promotion as well as to treat disease, especially in the United States - may be even more important than incentivising the development of new drugs.
The point of antibiotic overuse in farm animals drew praise from the the Alliance to Save Our Antibiotics and the UK-based Soil Association.
"If we are to have a chance of tackling the antibiotic resistance crisis, we need to change the way we farm," said Peter Melchett, Policy Director at the Soil Association. "Global livestock antibiotic use is forecast to increase by 67% by 2030, due to the expected increasing intensification of global livestock systems. We know that organic and extensive systems use far fewer antibiotics than intensive systems."
The O'Neill report comes on the heels of an analysis by the U.S. Centers for Disease Control and Prevention (CDC), in collaboration with Pew Charitable Trusts and other public health and medical experts, showing that at least 30 percent of antibiotics prescribed in the United States are unnecessary, while the U.S. Food and Drug Administration previously found that 80 percent of all antibiotics used in the United States were for livestock.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.